Jagsonpal Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
JAGSNPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Jagsonpal Pharmaceuticals has informed the stock exchange that its trading window has been closed for designated persons, as required under SEBI's Prohibition of Insider Trading Regulations, 2015. The trading window closure means that insiders, including directors, employees, and connected persons, are prohibited from trading in the company's shares during this period. This is a standard compliance measure typically undertaken ahead of a board meeting or material corporate event involving unpublished price-sensitive information. The specific reason and reopening date of the trading window are not mentioned in this filing.
This is a routine regulatory disclosure and does not directly affect the stock price or shareholders. Investors should watch for the company's next announcement, which will likely be a board meeting outcome (such as quarterly results or a corporate action) that triggered this window closure.